Log in
Enquire now
‌

US Patent 7750128 Modified Fc molecules

Patent 7750128 was granted and assigned to Amgen on July, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Amgen
Amgen
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7750128
Patent Inventor Names
Colin Gegg0
Fei Xiong0
Karen C. Sitney0
Date of Patent
July 6, 2010
Patent Application Number
12221417
Date Filed
August 1, 2008
Patent Citations Received
‌
US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
0
‌
US Patent 11685770 Stabilized receptor polypeptides and uses thereof
0
Patent Primary Examiner
‌
Sheela J. Huff
Patent abstract

The present invention concerns compositions of matter, for example, but not limited to, modified antibodies, in which one or more biologically active peptides are incorporated into a loop region of a non-terminal domain of an immunoglobulin Fc domain.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7750128 Modified Fc molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.